dc.contributor.author |
Nold P. |
|
dc.contributor.author |
Hartmann R. |
|
dc.contributor.author |
Feliu N. |
|
dc.contributor.author |
Kantner K. |
|
dc.contributor.author |
Gamal M. |
|
dc.contributor.author |
Pelaz B. |
|
dc.contributor.author |
Hühn J. |
|
dc.contributor.author |
Sun X. |
|
dc.contributor.author |
Jungebluth P. |
|
dc.contributor.author |
Del Pino P. |
|
dc.contributor.author |
Hackstein H. |
|
dc.contributor.author |
MacChiarini P. |
|
dc.contributor.author |
Parak W. |
|
dc.contributor.author |
Brendel C. |
|
dc.date.accessioned |
2020-01-15T22:05:37Z |
|
dc.date.available |
2020-01-15T22:05:37Z |
|
dc.date.issued |
2019 |
|
dc.identifier.uri |
https://dspace.kpfu.ru/xmlui/handle/net/156600 |
|
dc.description.abstract |
© 2019 The Author(s). Figure 5 was published incorrectly in the original publication of the article [1]. The correct version of Fig. 5 is given in this erratum. The authors apologize for the unfortunate error in the figure during publication of the article. It should also be clarified that some of the solid grey graphs in Fig. 5 are intentionally based on the same data. For 8 different surface makers (CD14, CD73, CD34, CD105, CD19, CD90, CD45, HA-DR) in accordance to the guidelines of the manufacturer a panel of 4 different isotype controls were used, corresponding to 4 different fluorescence channels. |
|
dc.title |
Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: A prerequisite for in vivo tracking of MSCs (Journal of Nanobiotechnology (2017) 15(24) DOI: 10.1186/s12951-017-0258-5) |
|
dc.type |
Erratum |
|
dc.relation.ispartofseries-issue |
1 |
|
dc.relation.ispartofseries-volume |
17 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.source.id |
SCOPUS-2019-17-1-SID85072303138 |
|